Clinical Trial Update: Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating DR30206 in combination with standard therapy for patients with gastrointestinal cancer is currently recruiting to assess p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• DR30206 (DR30206)

Snippet

Sponsor: Zhejiang Doer Biologics Co., Ltd. | Conditions: Gastrointestinal Cancer | Phase 1, Phase 2 | Status: RECRUITING